{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:23:23Z","timestamp":1783113803421,"version":"3.54.6"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.17708","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:30:13Z","timestamp":1597379413000},"page":"e2017708","source":"Crossref","is-referenced-by-count":63,"title":["Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19"],"prefix":"10.1001","volume":"3","author":[{"given":"Frank L.","family":"van de Veerdonk","sequence":"first","affiliation":[{"name":"Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse J. E.","family":"Kouijzer","sequence":"additional","affiliation":[{"name":"Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline H.","family":"de Nooijer","sequence":"additional","affiliation":[{"name":"Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"van der Hoeven","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen","family":"Maas","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[{"name":"Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands"},{"name":"Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands"},{"name":"Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J. M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands"},{"name":"Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"2","key":"zld200135r1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"zld200135r2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57555","article-title":"Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.","volume":"9","author":"van de Veerdonk","year":"2020","journal-title":"Elife"},{"issue":"8","key":"zld200135r4","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1007\/s00330-020-06817-6","article-title":"CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19).","volume":"30","author":"Li","year":"2020","journal-title":"Eur Radiol"},{"key":"zld200135r3","unstructured":"EPAR? Assessment Report 09-020-2018. Accessed April 2, 2020. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/firazyr"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2769237\/van_de_veerdonk_2020_ld_200135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:30:16Z","timestamp":1597379416000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2769237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.17708","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}